NCT04997122

Brief Summary

Healthy and at risk (hypercholesterolemic) subjects consumed during 4 weeks 45 g/d of either olive pomace oil (OPO) or high oleic acid sunflower oil (HOSO) as the only dietary fat in a randomized, crossover trial. The effects on blood lipids, glucose homeostasis, endothelial function, inflammatory cytokines, oxidative stress biomarkers and anthropometry were measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 2, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2018

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

August 4, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 9, 2021

Completed
Last Updated

August 16, 2021

Status Verified

August 1, 2021

Enrollment Period

3 months

First QC Date

August 4, 2021

Last Update Submit

August 8, 2021

Conditions

Keywords

Olive pomace oilLipaemiaGlucose homeostasisInflammationOxidative stress biomarkersEndothelial function

Outcome Measures

Primary Outcomes (1)

  • Blood lipids

    Changes on total or LDL-cholesterol levels or triglycerides in at risk (hypercholesterolemic) subjects. No effect on blood lipids expected in healthy (normocholesterolemic ) volunteers

    4 weeks

Secondary Outcomes (5)

  • Endothelial function

    4 weeks

  • Blood pressure

    4 weeks

  • Glucose homeostasis

    4 weeks

  • Inflammation

    4 weeks

  • Oxidative status

    4 weeks

Study Arms (2)

Olive pomace oil

EXPERIMENTAL

Intake of 45 g/d of olive pomace oil as the only source of oil in the diet

Other: Olive pomace oil

High-oleic sunflower oil

ACTIVE COMPARATOR

Intake of 45 g/d of high-oleic sunflower oil as the only source of oil in the diet

Other: High oleic acid sunflower oil

Interventions

Volunteers consumed during 4 weeks 45 g/d of olive pomace oil as the only source of dietary fat, used for cooking, salad dressing, toasts, etc.

Also known as: OPO
Olive pomace oil

Volunteers consumed during 4 weeks 45 g/d of oleic acid-rich sunflower oil as the only source of dietary fat, used for cooking, salad dressing, toasts, etc.

Also known as: HOSO
High-oleic sunflower oil

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy volunteers (Total cholesterol \< 200 mg/dL; LDL-cholesterol \< 135 mg/dL)
  • Hypercholesterolemic volunteers (Total cholesterol 200-300 mg/dL; LDL-cholesterol 135-175 mg/dL)

You may not qualify if:

  • BMI \> 30 Kg/m2
  • Smokers
  • Vegetarians
  • Pregnant women
  • Medication/consumption of vitamins, dietary supplements
  • On antibiotic treatment 3 months before starting the study
  • Digestive disorders/pathologies (gastric ulcer, Chron's disease, inflammatory bowel syndrome, etc.)
  • Food allergies/intolerances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de Ciencia y Tecnología de Alimentos y Nutrición

Madrid, 28040, Spain

Location

Related Publications (1)

  • Gonzalez-Ramila S, Sarria B, Seguido MA, Garcia-Cordero J, Mateos R, Bravo L. Olive pomace oil can improve blood lipid profile: a randomized, blind, crossover, controlled clinical trial in healthy and at-risk volunteers. Eur J Nutr. 2023 Mar;62(2):589-603. doi: 10.1007/s00394-022-03001-y. Epub 2022 Sep 24.

MeSH Terms

Conditions

HypercholesterolemiaHyperlipidemiasInflammation

Condition Hierarchy (Ancestors)

DyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Raquel Mateos, Dr

    ICTAN-CSIC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Oils were provided in unlabelled bottles (only differed in the colors of stoppers)
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: After a 3-week run-in, healthy and at risk (hypercholesterolemic) volunteers were randomly allocated to one of each arm. Eas intervention stage lasted 4 weeks and was separated fy a 3-week wash-out.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 4, 2021

First Posted

August 9, 2021

Study Start

April 2, 2018

Primary Completion

July 13, 2018

Study Completion

July 13, 2018

Last Updated

August 16, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations